An observational study of olanzapine coated and orodispersible tablets effectiveness in schizophrenic and bipolar outpatients.
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2015
At a glance
- Drugs Olanzapine (Primary)
- Indications Bipolar disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 01 Sep 2015 Results of post hoc analysis are presented at the 28th Annual Congress of the European College of Neuropsychopharmacology
- 05 Aug 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
- 05 Aug 2009 Actual patient number (1131) added as reported by ClinicalTrials.gov.